annual CAPEX:
$3.81B+$896.72M(+30.78%)Summary
- As of today (August 18, 2025), GSK annual capital expenditures is $3.81 billion, with the most recent change of +$896.72 million (+30.78%) on December 31, 2024.
- During the last 3 years, GSK annual CAPEX has risen by +$160.38 million (+4.39%).
- GSK annual CAPEX is now -11.15% below its all-time high of $4.29 billion, reached on December 31, 2007.
Performance
GSK CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$833.07M+$268.89M(+47.66%)Summary
- As of today (August 18, 2025), GSK quarterly capital expenditures is $833.07 million, with the most recent change of +$268.89 million (+47.66%) on June 30, 2025.
- Over the past year, GSK quarterly CAPEX has increased by +$276.84 million (+49.77%).
- GSK quarterly CAPEX is now -50.17% below its all-time high of $1.67 billion, reached on December 31, 2000.
Performance
GSK quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$3.97B+$276.84M(+7.49%)Summary
- As of today (August 18, 2025), GSK TTM capital expenditures is $3.97 billion, with the most recent change of +$276.84 million (+7.49%) on June 30, 2025.
- Over the past year, GSK TTM CAPEX has increased by +$1.12 billion (+39.29%).
- GSK TTM CAPEX is now -7.67% below its all-time high of $4.31 billion, reached on December 31, 2007.
Performance
GSK TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
GSK CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.8% | +49.8% | +39.3% |
| 3 y3 years | +4.4% | +46.0% | +7.0% |
| 5 y5 years | +38.1% | +66.9% | +62.4% |
GSK CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +37.0% | -44.7% | +49.8% | at high | +52.1% |
| 5 y | 5-year | at high | +38.1% | -49.9% | +70.7% | -1.8% | +62.4% |
| alltime | all time | -11.2% | +509.1% | -50.2% | +425.7% | -7.7% | >+9999.0% |
GSK CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $833.07M(+47.7%) | $3.97B(+7.5%) |
| Mar 2025 | - | $564.17M(-62.5%) | $3.70B(-3.9%) |
| Dec 2024 | $3.81B(+30.8%) | $1.51B(+40.4%) | $3.85B(+17.1%) |
| Sep 2024 | - | $1.07B(+92.8%) | $3.28B(+15.1%) |
| Jun 2024 | - | $556.23M(-22.1%) | $2.85B(-3.9%) |
| Mar 2024 | - | $713.85M(-24.2%) | $2.97B(+2.5%) |
| Dec 2023 | $2.91B(+4.8%) | $942.34M(+46.9%) | $2.90B(+2.8%) |
| Sep 2023 | - | $641.27M(-4.8%) | $2.82B(+2.9%) |
| Jun 2023 | - | $673.41M(+4.8%) | $2.74B(+3.9%) |
| Mar 2023 | - | $642.76M(-25.5%) | $2.64B(-4.4%) |
| Dec 2022 | $2.78B(-23.8%) | $862.89M(+53.7%) | $2.76B(+5.6%) |
| Sep 2022 | - | $561.29M(-1.6%) | $2.61B(-29.7%) |
| Jun 2022 | - | $570.40M(-25.4%) | $3.72B(-5.2%) |
| Mar 2022 | - | $764.38M(+6.7%) | $3.92B(+7.6%) |
| Dec 2021 | $3.65B(+27.1%) | $716.50M(-56.9%) | $3.65B(-9.9%) |
| Sep 2021 | - | $1.66B(+114.4%) | $4.05B(+26.6%) |
| Jun 2021 | - | $776.23M(+59.0%) | $3.19B(+9.5%) |
| Mar 2021 | - | $488.13M(-56.3%) | $2.92B(+1.7%) |
| Dec 2020 | $2.87B(+4.1%) | $1.12B(+37.4%) | $2.87B(+6.5%) |
| Sep 2020 | - | $813.08M(+62.9%) | $2.69B(+10.1%) |
| Jun 2020 | - | $499.22M(+13.6%) | $2.45B(-11.9%) |
| Mar 2020 | - | $439.52M(-53.4%) | $2.78B(+1.6%) |
| Dec 2019 | $2.76B(+15.2%) | $942.39M(+66.2%) | $2.73B(+3.6%) |
| Sep 2019 | - | $566.91M(-31.6%) | $2.64B(+0.6%) |
| Jun 2019 | - | $828.52M(+109.3%) | $2.62B(+13.3%) |
| Mar 2019 | - | $395.92M(-53.2%) | $2.31B(-4.1%) |
| Dec 2018 | $2.39B(-15.6%) | $846.28M(+53.7%) | $2.41B(-1.3%) |
| Sep 2018 | - | $550.59M(+5.9%) | $2.44B(-4.1%) |
| Jun 2018 | - | $519.90M(+5.2%) | $2.55B(-9.2%) |
| Mar 2018 | - | $494.01M(-43.7%) | $2.81B(-0.8%) |
| Dec 2017 | $2.84B(-10.4%) | $877.67M(+33.8%) | $2.83B(-3.0%) |
| Sep 2017 | - | $655.88M(-15.8%) | $2.92B(+0.3%) |
| Jun 2017 | - | $778.57M(+51.0%) | $2.91B(+3.6%) |
| Mar 2017 | - | $515.48M(-46.6%) | $2.80B(-11.4%) |
| Dec 2016 | $3.17B(+9.0%) | $965.55M(+49.5%) | $3.17B(-2.4%) |
| Sep 2016 | - | $645.78M(-4.6%) | $3.24B(-1.1%) |
| Jun 2016 | - | $677.08M(-22.8%) | $3.28B(+1.1%) |
| Mar 2016 | - | $876.79M(-16.0%) | $3.24B(+11.2%) |
| Dec 2015 | $2.90B(+0.7%) | $1.04B(+53.3%) | $2.92B(+3.3%) |
| Sep 2015 | - | $680.87M(+6.3%) | $2.82B(-0.7%) |
| Jun 2015 | - | $640.37M(+16.1%) | $2.84B(-0.9%) |
| Mar 2015 | - | $551.37M(-42.1%) | $2.87B(-1.0%) |
| Dec 2014 | $2.88B(+8.2%) | $951.74M(+36.0%) | $2.90B(+4.6%) |
| Sep 2014 | - | $699.83M(+5.1%) | $2.77B(+0.1%) |
| Jun 2014 | - | $665.94M(+14.8%) | $2.77B(+0.5%) |
| Mar 2014 | - | $580.09M(-29.5%) | $2.75B(+3.3%) |
| Dec 2013 | $2.66B(+10.6%) | $823.11M(+18.0%) | $2.66B(-0.6%) |
| Sep 2013 | - | $697.77M(+7.1%) | $2.68B(+4.0%) |
| Jun 2013 | - | $651.60M(+32.5%) | $2.58B(+3.1%) |
| Mar 2013 | - | $491.62M(-41.4%) | $2.50B(+3.8%) |
| Dec 2012 | $2.41B(+13.1%) | $839.45M(+41.1%) | $2.41B(+4.3%) |
| Sep 2012 | - | $595.13M(+3.5%) | $2.31B(+5.9%) |
| Jun 2012 | - | $575.07M(+43.5%) | $2.18B(+3.6%) |
| Mar 2012 | - | $400.63M(-45.9%) | $2.11B(-1.4%) |
| Dec 2011 | $2.13B | $740.25M(+58.5%) | $2.14B(+1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | $467.14M(-6.5%) | $2.10B(-13.7%) |
| Jun 2011 | - | $499.60M(+15.9%) | $2.43B(+4.3%) |
| Mar 2011 | - | $431.00M(-38.5%) | $2.33B(+5.0%) |
| Dec 2010 | $2.52B(-14.1%) | $700.46M(-12.6%) | $2.22B(-12.6%) |
| Sep 2010 | - | $801.57M(+100.2%) | $2.54B(+6.8%) |
| Jun 2010 | - | $400.31M(+25.0%) | $2.38B(-7.8%) |
| Mar 2010 | - | $320.28M(-68.6%) | $2.58B(-2.4%) |
| Dec 2009 | $2.94B(-22.8%) | $1.02B(+59.6%) | $2.65B(-9.9%) |
| Sep 2009 | - | $638.83M(+6.0%) | $2.94B(-9.5%) |
| Jun 2009 | - | $602.87M(+56.9%) | $3.24B(-2.4%) |
| Mar 2009 | - | $384.17M(-70.7%) | $3.33B(-3.5%) |
| Dec 2008 | $3.81B(-11.2%) | $1.31B(+38.6%) | $3.45B(+1.5%) |
| Sep 2008 | - | $946.01M(+38.3%) | $3.39B(+2.5%) |
| Jun 2008 | - | $684.17M(+35.5%) | $3.31B(-3.4%) |
| Mar 2008 | - | $505.01M(-59.9%) | $3.43B(-20.4%) |
| Dec 2007 | $4.29B(+46.5%) | $1.26B(+46.1%) | $4.31B(+10.1%) |
| Sep 2007 | - | $861.84M(+7.7%) | $3.91B(+4.6%) |
| Jun 2007 | - | $799.91M(-42.2%) | $3.74B(+7.6%) |
| Mar 2007 | - | $1.38B(+60.2%) | $3.48B(+39.2%) |
| Dec 2006 | $2.93B(+36.4%) | $863.89M(+24.9%) | $2.50B(+10.8%) |
| Sep 2006 | - | $691.45M(+28.8%) | $2.25B(+13.3%) |
| Jun 2006 | - | $536.75M(+32.6%) | $1.99B(+9.8%) |
| Mar 2006 | - | $404.81M(-34.7%) | $1.81B(+10.0%) |
| Dec 2005 | $2.15B(+12.4%) | $620.34M(+45.4%) | $1.65B(+7.2%) |
| Sep 2005 | - | $426.61M(+18.6%) | $1.54B(+5.0%) |
| Jun 2005 | - | $359.74M(+50.2%) | $1.46B(+1.2%) |
| Mar 2005 | - | $239.46M(-53.1%) | $1.45B(+1.2%) |
| Dec 2004 | $1.91B(+10.1%) | $510.17M(+44.3%) | $1.43B(-2.6%) |
| Sep 2004 | - | $353.44M(+3.3%) | $1.47B(+2.8%) |
| Jun 2004 | - | $342.21M(+53.9%) | $1.43B(+3.2%) |
| Mar 2004 | - | $222.39M(-59.4%) | $1.38B(-1.6%) |
| Dec 2003 | $1.73B(-5.7%) | $548.06M(+74.7%) | $1.41B(-5.7%) |
| Sep 2003 | - | $313.70M(+5.1%) | $1.49B(-2.6%) |
| Jun 2003 | - | $298.51M(+21.7%) | $1.53B(-2.2%) |
| Mar 2003 | - | $245.22M(-61.3%) | $1.56B(-0.4%) |
| Dec 2002 | $1.84B(-2.5%) | $633.22M(+79.0%) | $1.57B(-0.7%) |
| Sep 2002 | - | $353.72M(+6.5%) | $1.58B(-0.7%) |
| Jun 2002 | - | $332.26M(+32.4%) | $1.59B(+1.4%) |
| Mar 2002 | - | $250.99M(-61.0%) | $1.57B(-2.0%) |
| Dec 2001 | $1.89B(+13.1%) | $643.88M(+76.5%) | $1.60B(-39.1%) |
| Sep 2001 | - | $364.76M(+17.7%) | $2.63B(+30.9%) |
| Jun 2001 | - | $309.88M(+9.5%) | $2.01B(+28.8%) |
| Mar 2001 | - | $282.93M(-83.1%) | $1.56B(-6.7%) |
| Dec 2000 | $1.67B(-17.1%) | $1.67B(-753.6%) | $1.67B(>+9900.0%) |
| Sep 2000 | - | -$255.77M(+83.7%) | $0.00(-100.0%) |
| Jun 2000 | - | -$139.20M(-135.2%) | $255.77M(-35.2%) |
| Mar 2000 | - | $394.97M | $394.97M |
| Dec 1999 | $2.01B(+155.6%) | - | - |
| Dec 1998 | $787.20M(+15.8%) | - | - |
| Dec 1997 | $679.62M(+8.6%) | - | - |
| Dec 1996 | $625.63M(-42.0%) | - | - |
| Dec 1995 | $1.08B(+25.4%) | - | - |
| Jun 1994 | $860.88M(-12.0%) | - | - |
| Jun 1993 | $977.77M(-6.2%) | - | - |
| Jun 1992 | $1.04B(-12.1%) | - | - |
| Jun 1991 | $1.19B | - | - |
FAQ
- What is GSK plc annual capital expenditures?
- What is the all time high annual CAPEX for GSK plc?
- What is GSK plc annual CAPEX year-on-year change?
- What is GSK plc quarterly capital expenditures?
- What is the all time high quarterly CAPEX for GSK plc?
- What is GSK plc quarterly CAPEX year-on-year change?
- What is GSK plc TTM capital expenditures?
- What is the all time high TTM CAPEX for GSK plc?
- What is GSK plc TTM CAPEX year-on-year change?
What is GSK plc annual capital expenditures?
The current annual CAPEX of GSK is $3.81B
What is the all time high annual CAPEX for GSK plc?
GSK plc all-time high annual capital expenditures is $4.29B
What is GSK plc annual CAPEX year-on-year change?
Over the past year, GSK annual capital expenditures has changed by +$896.72M (+30.78%)
What is GSK plc quarterly capital expenditures?
The current quarterly CAPEX of GSK is $833.07M
What is the all time high quarterly CAPEX for GSK plc?
GSK plc all-time high quarterly capital expenditures is $1.67B
What is GSK plc quarterly CAPEX year-on-year change?
Over the past year, GSK quarterly capital expenditures has changed by +$276.84M (+49.77%)
What is GSK plc TTM capital expenditures?
The current TTM CAPEX of GSK is $3.97B
What is the all time high TTM CAPEX for GSK plc?
GSK plc all-time high TTM capital expenditures is $4.31B
What is GSK plc TTM CAPEX year-on-year change?
Over the past year, GSK TTM capital expenditures has changed by +$1.12B (+39.29%)